EP3207132

ALEXION PHARMACEUTICALS, INC.
Application Number
EP15795064A
Filing Date
Oct 13, 2015
Status
Granted And Under Opposition
Jun 28, 2019
Grant Date
Jul 31, 2019
External Links
Slate, Register

Biblio Summary

The patent EP3207132B1 was granted on Jul 31, 2019 by Alexion Pharmaceuticals, Inc. The patent is currently Granted And Under Opposition.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STOLMAR, MATTHIASApr 30, 2020ADMISSIBLE

The table below shows the patents of Alexion Pharmaceuticals, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3167888Behandlung Von Patienten Mit Paroxysmaler Nachtlicher Hamoglobinurie Mit Einem KomplementinhibitorMay 1, 20241
EP2894165Methods And Compositions For Treating Complement-Associated DisordersJan 4, 20232
EP2978451Compositions And Methods For Increasing The Serum Half-Life Of A Therapeutic Agent Targeting Complement C5Nov 27, 20192